A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection
RANTES (CCL5) is a chemokine expressed by many hematopoietic and non-hematopoietic cell types that plays an important role in homing and migration of effector and memory T cells during acute infections. The RANTES receptor, CCR5, is a major target of anti-HIV drugs based on blocking viral entry. However, defects in RANTES or RANTES receptors including CCR5 can compromise immunity to acute infections in animal models and lead to more severe disease in humans infected with west Nile virus (WNV). In contrast, the role of the RANTES pathway in regulating T cell responses and immunity during chronic infection remains unclear. In this study, we demonstrate a crucial role for RANTES in the control of systemic chronic LCMV infection. In RANTES−/− mice, virus-specific CD8 T cells had poor cytokine production. These RANTES−/− CD8 T cells also expressed higher amounts of inhibitory receptors consistent with more severe exhaustion. Moreover, the cytotoxic ability of CD8 T cells from RANTES−/− mice was reduced. Consequently, viral load was higher in the absence of RANTES. The dysfunction of T cells in the absence of RANTES was as severe as CD8 T cell responses generated in the absence of CD4 T cell help. Our results demonstrate an important role for RANTES in sustaining CD8 T cell responses during a systemic chronic viral infection.
Vyšlo v časopise:
A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection. PLoS Pathog 7(7): e32767. doi:10.1371/journal.ppat.1002098
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002098
Souhrn
RANTES (CCL5) is a chemokine expressed by many hematopoietic and non-hematopoietic cell types that plays an important role in homing and migration of effector and memory T cells during acute infections. The RANTES receptor, CCR5, is a major target of anti-HIV drugs based on blocking viral entry. However, defects in RANTES or RANTES receptors including CCR5 can compromise immunity to acute infections in animal models and lead to more severe disease in humans infected with west Nile virus (WNV). In contrast, the role of the RANTES pathway in regulating T cell responses and immunity during chronic infection remains unclear. In this study, we demonstrate a crucial role for RANTES in the control of systemic chronic LCMV infection. In RANTES−/− mice, virus-specific CD8 T cells had poor cytokine production. These RANTES−/− CD8 T cells also expressed higher amounts of inhibitory receptors consistent with more severe exhaustion. Moreover, the cytotoxic ability of CD8 T cells from RANTES−/− mice was reduced. Consequently, viral load was higher in the absence of RANTES. The dysfunction of T cells in the absence of RANTES was as severe as CD8 T cell responses generated in the absence of CD4 T cell help. Our results demonstrate an important role for RANTES in sustaining CD8 T cell responses during a systemic chronic viral infection.
Zdroje
1. SallustoFMackayCRLanzavecchiaA 2000 The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 18 593 620
2. EscheCStellatoCBeckLA 2005 Chemokines: key players in innate and adaptive immunity. J Invest Dermatol 125 615 628
3. LoetscherPSeitzMClark-LewisIBaggioliniMMoserB 1996 Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release. J Immunol 156 322 327
4. SchallTJBaconKToyKJGoeddelDV 1990 Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 669 671
5. RotAKriegerMBrunnerTBischoffSCSchallTJ 1992 RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J Exp Med 176 1489 1495
6. DieuMCVanbervlietBVicariABridonJMOldhamE 1998 Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 188 373 386
7. CastellinoFHuangAYAltan-BonnetGStollSScheineckerC 2006 Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 440 890 895
8. MatloubianMConcepcionRJAhmedR 1994 CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection. J Virol 68 8056 8063
9. GrakouiAShoukryNHWoollardDJHanJHHansonHL 2003 HCV persistence and immune evasion in the absence of memory T cell help. Science 302 659 662
10. LechnerFWongDKDunbarPRChapmanRChungRT 2000 Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med 191 1499 1512
11. ZajacAJBlattmanJNMurali-KrishnaKSourdiveDJSureshM 1998 Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188 2205 2213
12. SaitoTDeskinRWCasolaAHaeberleHOlszewskaB 1997 Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis 175 497 504
13. HaoXKimTSBracialeTJ 2008 Differential response of respiratory dendritic cell subsets to influenza virus infection. J Virol 82 4908 4919
14. CulleyFJPennycookAMTregoningJSHussellTOpenshawPJ 2006 Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J Virol 80 4521 4527
15. MatsukuraSKokubuFKuboHTomitaTTokunagaH 1998 Expression of RANTES by normal airway epithelial cells after influenza virus A infection. Am J Respir Cell Mol Biol 18 255 264
16. ChanMCCheungCYChuiWHTsaoSWNichollsJM 2005 Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6 135
17. WareingMDLyonABLuBGerardCSarawarSR 2004 Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J Leukoc Biol 76 886 895
18. GraysonMHRamosMSRohlfingMMKitchensRWangHD 2007 Controls for lung dendritic cell maturation and migration during respiratory viral infection. J Immunol 179 1438 1448
19. TynerJWUchidaOKajiwaraNKimEYPatelAC 2005 CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat Med 11 1180 1187
20. KohlmeierJEMillerSCSmithJLuBGerardC 2008 The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections. Immunity 29 101 113
21. GlassWGLimJKCholeraRPletnevAGGaoJL 2005 Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med 202 1087 1098
22. LimJKMcDermottDHLiscoAFosterGAKrysztofD 2010 CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission. J Infect Dis 201 178 185
23. DragicTLitwinVAllawayGPMartinSRHuangY 1996 HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 381 667 673
24. DoranzBJRuckerJYiYSmythRJSamsonM 1996 A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85 1149 1158
25. DolanMJKulkarniHCamargoJFHeWSmithA 2007 CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol 8 1324 1336
26. FatkenheuerGPozniakALJohnsonMAPlettenbergAStaszewskiS 2005 Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nat Med 11 1170 1172
27. GlassWGMcDermottDHLimJKLekhongSYuSF 2006 CCR5 deficiency increases risk of symptomatic West Nile virus infection. J Exp Med 203 35 40
28. KindbergEMickieneAAxCAkerlindBVeneS 2008 A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 197 266 269
29. AsensioVCCampbellIL 1997 Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol 71 7832 7840
30. MuellerSNHosiawa-MeagherKAKoniecznyBTSullivanBMBachmannMF 2007 Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317 670 674
31. WherryEJBlattmanJNMurali-KrishnaKvan der MostRAhmedR 2003 Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77 4911 4927
32. BarberDLWherryEJMasopustDZhuBAllisonJP 2006 Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439 682 687
33. HermansIFSilkJDYangJPalmowskiMJGileadiU 2004 The VITAL assay: a versatile fluorometric technique for assessing CTL- and NKT-mediated cytotoxicity against multiple targets in vitro and in vivo. J Immunol Methods 285 25 40
34. ShedlockDJShenH 2003 Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300 337 339
35. SunJCBevanMJ 2003 Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300 339 342
36. JanssenEMDroinNMLemmensEEPinkoskiMJBensingerSJ 2005 CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death. Nature 434 88 93
37. WherryEJHaSJKaechSMHainingWNSarkarS 2007 Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27 670 684
38. BlackburnSDShinHHainingWNZouTWorkmanCJ 2009 Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 10 29 37
39. ZhouSHalleAKurt-JonesEACernyAMPorpigliaE 2008 Lymphocytic choriomeningitis virus (LCMV) infection of CNS glial cells results in TLR2-MyD88/Mal-dependent inflammatory responses. J Neuroimmunol 194 70 82
40. EberleinJNguyenTTVictorinoFGolden-MasonLRosenHR 2010 Comprehensive assessment of chemokine expression profiles by flow cytometry. J Clin Invest 120 907 923
41. CatalfamoMKarpovaTMcNallyJCostesSVLockettSJ 2004 Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity 20 219 230
42. FullerMJKhanolkarATeboAEZajacAJ 2004 Maintenance, loss, and resurgence of T cell responses during acute, protracted, and chronic viral infections. J Immunol 172 4204 4214
43. WalshCMMatloubianMLiuCCUedaRKuraharaCG 1994 Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A 91 10854 10858
44. LeistTPEpplerMZinkernagelRM 1989 Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice. J Virol 63 2813 2819
45. SeilerPAichelePOdermattBHengartnerHZinkernagelRM 1997 Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol 27 2626 2633
46. MatloubianMSomasundaramTKolhekarSRSelvakumarRAhmedR 1990 Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. J Exp Med 172 1043 1048
47. BaconKBPremackBAGardnerPSchallTJ 1995 Activation of dual T cell signaling pathways by the chemokine RANTES. Science 269 1727 1730
48. MolonBGriGBettellaMGomez-MoutonCLanzavecchiaA 2005 T cell costimulation by chemokine receptors. Nat Immunol 6 465 471
49. MullerUSteinhoffUReisLFHemmiSPavlovicJ 1994 Functional role of type I and type II interferons in antiviral defense. Science 264 1918 1921
50. HuangSHendriksWAlthageAHemmiSBluethmannH 1993 Immune response in mice that lack the interferon-gamma receptor. Science 259 1742 1745
51. SullivanBMJuedesASzaboSJvon HerrathMGlimcherLH 2003 Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A 100 15818 15823
52. IntlekoferAMBanerjeeATakemotoNGordonSMDejongCS 2008 Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321 408 411
53. GalvaniAPSlatkinM 2003 Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele. Proc Natl Acad Sci U S A 100 15276 15279
54. PulendranBMillerJQuerecTDAkondyRMoseleyN 2008 Case of yellow fever vaccine–associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis 198 500 507
55. ThioCLSeabergECSkolaskyRJrPhairJVisscherB 2002 HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360 1921 1926
56. ZhouJDoreGJZhangFLimPLChenYM 2007 Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. J Gastroenterol Hepatol 22 1510 1518
57. AlterMJ 2006 Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44 S6 9
58. ZeremskiMPetrovicLMTalalAH 2007 The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14 675 687
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 7
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- Requires Glycerol for Maximum Fitness During The Tick Phase of the Enzootic Cycle
- Comparative Genomics Yields Insights into Niche Adaptation of Plant Vascular Wilt Pathogens
- The Role of IL-15 Deficiency in the Pathogenesis of Virus-Induced Asthma Exacerbations
- “Persisters”: Survival at the Cellular Level